Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combination Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04970914
What this trial is testing

Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003

Who this might be right for
Colorectal Cancer
Peking Union Medical College Hospital 32
Large-scale testing (Phase 3)Looking for participantsNCT07549321
What this trial is testing

A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

Who this might be right for
High-Risk Neuroblastoma
Renaissance Pharma Ltd. 144
Testing effectiveness (Phase 2)Study completedNCT00005798
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 209
Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Testing effectiveness (Phase 2)UnknownNCT02862561
What this trial is testing

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Precision Cell ImmunotherapyChemotherapyAdvanced Malignancies
Shanghai International Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT06094296
What this trial is testing

BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC
Bristol-Myers Squibb 1
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Large-scale testing (Phase 3)Study completedNCT04712903
What this trial is testing

Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 101
Early research (Phase 1)Study completedNCT00621361
What this trial is testing

Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients

Who this might be right for
Lung Cancer
AstraZeneca 62
Early research (Phase 1)Study completedNCT00004862
What this trial is testing

Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)UnknownNCT04077983
What this trial is testing

Nab-Paclitaxel Combined With Gemcitabine Adjuvant Chemotherapy After Radical Resection of Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 40
Early research (Phase 1)Study completedNCT01835041
What this trial is testing

CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Wake Forest University Health Sciences 21
Large-scale testing (Phase 3)UnknownNCT04361305
What this trial is testing

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

Who this might be right for
Premature EjaculationErectile Dysfunction
Yan-Ping Huang 150
Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Post-approval studies (Phase 4)Study completedNCT00294294
What this trial is testing

Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa

Who this might be right for
Vaccines, PneumococcalInfantFever, Chemically Induced+1 more
Wyeth is now a wholly owned subsidiary of Pfizer 300
Testing effectiveness (Phase 2)Looking for participantsNCT06825546
What this trial is testing

Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital 70
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Testing effectiveness (Phase 2)Looking for participantsNCT06718205
What this trial is testing

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 112
Early research (Phase 1)Not Yet RecruitingNCT07637786
What this trial is testing

Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Adenocarcinoma
Sichuan University 9
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Next Page